Alignment Healthcare, Inc. Common Stock
ALHCAlignment Healthcare, Inc. is a healthcare technology company focused on providing innovative Medicare Advantage plans and related services. Founded to improve the quality and affordability of senior healthcare, it leverages data-driven, personalized care models to enhance patient outcomes. The company emphasizes integrated care delivery and partnerships with healthcare providers.
Company News
Hagens Berman is investigating Alignment Healthcare (ALHC) following whistleblower allegations that the company engaged in accounting irregularities by misclassifying operating expenses as capital expenditures to inflate EBITDA and financial results for 2024-2025. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst...
Block & Leviton is investigating Unicycive Therapeutics for potential securities law violations related to false or misleading statements about FDA review of its OLC New Drug Application. The company received a second Complete Response Letter on June 30, 2026, citing manufacturing deficiencies, which led to a stock price decline. Investors who ha...
Hagens Berman is investigating Alignment Healthcare (ALHC) following whistleblower allegations that the company engaged in accounting irregularities, misclassifying operating expenses as capital expenditures to inflate EBITDA and financial metrics. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance sin...
Block & Leviton is investigating Alignment Healthcare, Inc. (ALHC) for potential securities law violations following allegations that a former executive filed a whistleblower lawsuit claiming the company manipulated finances to boost stock price and executive compensation. The stock fell approximately 16.72% following the report. The firm is also...
Law firm Johnson Fistel announced an investigation into Alignment Healthcare (NASDAQ: ALHC) following a whistleblower lawsuit filed by a former executive alleging the company manipulated its finances to boost stock price and executive compensation. The firm is investigating whether the company complied with federal securities laws and is seeking ...
